Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-061816
Filing Date
2025-06-23
Accepted
2025-06-23 18:41:28
Documents
1
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518376-13_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2518376-13_4seq1.xml 4 4130
  Complete submission text file 0001104659-25-061816.txt   5595
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Lubner David Charles (Reporting) CIK: 0001572000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 251066252